Tactive Advisors’s Eli Lilly LLY Stock Holding History

Tactive Advisors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$907K	Buy	756 +157	+26%	+$160K	0.22%	94
2026 Q1	$551K	Buy	599 +53	+10%	+$53.7K	0.16%	131
2025 Q4	$587K	Sell	546 -194	-26%	-$185K	0.17%	128
2025 Q3	$565K	Sell	740 -109	-13%	-$81.1K	0.16%	131
2025 Q2	$662K	Buy	+849	New	+$660K	0.21%	107
2024 Q1	$961K	Buy	1,235 +433	+54%	+$308K	0.51%	46
2023 Q4	$468K	Sell	802 -433	-35%	-$253K	0.3%	46
2023 Q3	$663K	Buy	+1,235	New	+$636K	0.57%	28

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

GIM

Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Tactive Advisors's LLY Position: Q2 2026 in Review

Tactive Advisors increased its Eli Lilly (LLY) stake by 26% in Q2 2026, buying an estimated $160K and bringing the position to 756 shares worth $907K. The position accounts for 0.22% of the portfolio, ranked #94.

Tactive Advisors first reported a position in LLY in Q3 2023 and has held it in 8 quarters since. The position peaked at $961K in Q1 2024. 1,651 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Tactive Advisors held 756 shares of Eli Lilly worth $907K as of Q2 2026.
Tactive Advisors bought 157 Eli Lilly shares in Q2 2026, an estimated $160K.
Eli Lilly made up 0.22% of Tactive Advisors's portfolio in Q2 2026, its #94 holding.
Tactive Advisors first reported a position in Eli Lilly in Q3 2023 and has held it in 8 quarters since.
Tactive Advisors's Eli Lilly position peaked at $961K in Q1 2024.
1,651 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Tactive Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.